OrbiMed Advisors Discloses Investment at Electra Therapeutics with 11.0% Stake

OrbiMed Advisors LLC disclosed an 11.0% stake in Electra Therapeutics, Inc. common stock. The filing, dated September 25, 2026, follows Electra Therapeutics’ IPO and the conversion of preferred shares into common stock. The position reflects a significant life sciences investor taking a meaningful…